Trial Profile

Pharmacokinetics of Ertapenem Following Subcutaneous or Intravenous Infusion in Patients Aged Over 75 (PHACINERTA)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ertapenem (Primary) ; Ertapenem (Primary)
Indications Bacterial infections
Focus Pharmacokinetics
Acronyms PHACINERTA

Most Recent Events

01 Dec 2019 Results reporting and comparing ertapenem pharmacokinetic data between IV and SC routes in older persons published in the Journal of Antimicrobial Chemotherapy
24 Apr 2018 Results presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
14 Sep 2016 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com